250 related articles for article (PubMed ID: 33681944)
1. Azeliragon ameliorates Alzheimer's disease via the Janus tyrosine kinase and signal transducer and activator of transcription signaling pathway.
Yang L; Liu Y; Wang Y; Li J; Liu N
Clinics (Sao Paulo); 2021; 76():e2348. PubMed ID: 33681944
[TBL] [Abstract][Full Text] [Related]
2. TTP488 ameliorates NLRP3-associated inflammation, viability, apoptosis, and ROS production in an Alzheimer's disease cell model by mediating the JAK1/STAT3/NFκB/IRF3 pathway.
Xue J; Jia P; Zhang D; Yao Z
Cell Biochem Funct; 2021 Jun; 39(4):555-561. PubMed ID: 33724512
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Real-World Clinical Data, Combined with Empirical Validation, Nominate Jak-Stat Signaling as a Target for Alzheimer's Disease Therapeutic Development.
Nevado-Holgado AJ; Ribe E; Thei L; Furlong L; Mayer MA; Quan J; Richardson JC; Cavanagh J; Consortium N; Lovestone S
Cells; 2019 May; 8(5):. PubMed ID: 31072055
[TBL] [Abstract][Full Text] [Related]
4. Folic Acid Alters Methylation Profile of JAK-STAT and Long-Term Depression Signaling Pathways in Alzheimer's Disease Models.
Li W; Liu H; Yu M; Zhang X; Zhang Y; Liu H; Wilson JX; Huang G
Mol Neurobiol; 2016 Nov; 53(9):6548-6556. PubMed ID: 26627706
[TBL] [Abstract][Full Text] [Related]
5. Effect of microRNA-186 on oxidative stress injury of neuron by targeting interleukin 2 through the janus kinase-signal transducer and activator of transcription pathway in a rat model of Alzheimer's disease.
Wu DM; Wen X; Wang YJ; Han XR; Wang S; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Chen GQ; Zheng YL
J Cell Physiol; 2018 Dec; 233(12):9488-9502. PubMed ID: 29995978
[TBL] [Abstract][Full Text] [Related]
6. FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK/STAT signaling pathway.
Wang L; Zhao D; Wang H; Wang L; Liu X; Zhang H
Int Immunopharmacol; 2021 Nov; 100():108117. PubMed ID: 34509933
[TBL] [Abstract][Full Text] [Related]
7. JAK-STAT-dependent regulation of scavenger receptors in LPS-activated murine macrophages.
Hashimoto R; Kakigi R; Miyamoto Y; Nakamura K; Itoh S; Daida H; Okada T; Katoh Y
Eur J Pharmacol; 2020 Mar; 871():172940. PubMed ID: 31968212
[TBL] [Abstract][Full Text] [Related]
8. Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways.
Ibrahim SSA; Salama MA; Selima E; Shehata RR
Life Sci; 2020 Nov; 260():118261. PubMed ID: 32795539
[TBL] [Abstract][Full Text] [Related]
9. Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease.
Burstein AH; Sabbagh M; Andrews R; Valcarce C; Dunn I; Altstiel L
J Prev Alzheimers Dis; 2018; 5(2):149-154. PubMed ID: 29616709
[TBL] [Abstract][Full Text] [Related]
10. Effect of TTP488 in patients with mild to moderate Alzheimer's disease.
Burstein AH; Grimes I; Galasko DR; Aisen PS; Sabbagh M; Mjalli AM
BMC Neurol; 2014 Jan; 14():12. PubMed ID: 24423155
[TBL] [Abstract][Full Text] [Related]
11. The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer's Disease: New Potential Treatment Target.
Rusek M; Smith J; El-Khatib K; Aikins K; Czuczwar SJ; Pluta R
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614305
[TBL] [Abstract][Full Text] [Related]
12. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway.
Ruganzu JB; Zheng Q; Wu X; He Y; Peng X; Jin H; Zhou J; Ma R; Ji S; Ma Y; Qian Y; Wang Y; Yang W
Exp Neurol; 2021 Feb; 336():113506. PubMed ID: 33065077
[TBL] [Abstract][Full Text] [Related]
13. Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis
Palmroth M; Kuuliala K; Peltomaa R; Virtanen A; Kuuliala A; Kurttila A; Kinnunen A; Leirisalo-Repo M; Silvennoinen O; Isomäki P
Front Immunol; 2021; 12():738481. PubMed ID: 34630419
[TBL] [Abstract][Full Text] [Related]
14. Chaiqin Chengqi decoction inhibits inflammatory mediators and attenuates acute pancreatitis through deactivation of janus kinase/signal transducer and activator of transcription signaling pathway.
Dong J; Chen X; Song Y; Fei X
J Tradit Chin Med; 2019 Apr; 39(2):166-173. PubMed ID: 32186038
[TBL] [Abstract][Full Text] [Related]
15. AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway.
Tsogbadrakh B; Ryu H; Ju KD; Lee J; Yun S; Yu KS; Kim HJ; Ahn C; Oh KH
Biochem Biophys Res Commun; 2019 Feb; 509(3):680-686. PubMed ID: 30616891
[TBL] [Abstract][Full Text] [Related]
16. SOCE-mediated NFAT1-NOX2-NLRP1 inflammasome involves in lipopolysaccharide-induced neuronal damage and Aβ generation.
Sun Z; Li X; Yang L; Dong X; Han Y; Li Y; Luo J; Li W
Mol Neurobiol; 2022 May; 59(5):3183-3205. PubMed ID: 35286582
[TBL] [Abstract][Full Text] [Related]
17. Chronic perinatal hypoxia reduces glutamate-aspartate transporter function in astrocytes through the Janus kinase/signal transducer and activator of transcription pathway.
Raymond M; Li P; Mangin JM; Huntsman M; Gallo V
J Neurosci; 2011 Dec; 31(49):17864-71. PubMed ID: 22159101
[TBL] [Abstract][Full Text] [Related]
18. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
19. JAK/STAT pathway regulation of GABAA receptor expression after differing severities of experimental TBI.
Raible DJ; Frey LC; Del Angel YC; Carlsen J; Hund D; Russek SJ; Smith B; Brooks-Kayal AR
Exp Neurol; 2015 Sep; 271():445-56. PubMed ID: 26172316
[TBL] [Abstract][Full Text] [Related]
20. Sodium Houttuyfonate Ameliorates
Zhao Y; Tian Y; Feng T
Mediators Inflamm; 2021; 2021():8817698. PubMed ID: 34188608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
